We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+7.56%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$40.8B
AUM Growth
+$3.42B
(+9.2%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
25.28%
Holding
2,151
New
303
Increased
1,108
Reduced
653
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$197M |
| 2 |
Walmart Inc
WMT
|
+$193M |
| 3 |
NextEra Energy
NEE
|
+$177M |
| 4 |
Apple
AAPL
|
+$129M |
| 5 |
UnitedHealth
UNH
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$230M |
| 2 |
Sysco
SYY
|
+$164M |
| 3 |
Synopsys
SNPS
|
+$81.2M |
| 4 |
C.H. Robinson
CHRW
|
+$53.8M |
| 5 |
United Bankshares
UBSI
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.01% |
| 2 | Consumer Staples | 11.62% |
| 3 | Industrials | 10.88% |
| 4 | Consumer Discretionary | 9.53% |
| 5 | Healthcare | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Surgery Partners
SGRY
$2.06B
| $468K | ﹤0.01% |
14,513
-5,747
| -28% | -$170K |
|
1177
Rapid7
RPD
$634M
| $467K | ﹤0.01% |
11,698
+3,572
| +44% | +$134K |
|
1178
Ligand Pharmaceuticals
LGND
$6.02B
| $466K | ﹤0.01% |
4,654
+951
| +26% | +$95.7K |
|
1179
Worthington Steel
WS
$1.8B
| $465K | ﹤0.01% |
13,664
-193,636
| -93% | -$6.65M |
|
|
CPRX
1180
DELISTED
Catalyst Pharmaceutical
CPRX
| $464K | ﹤0.01% |
23,320
+6,158
| +36% | +$114K |
|
1181
CONMED
CNMD
$1.29B
| $463K | ﹤0.01% |
6,435
+1,712
| +36% | +$121K |
|
1182
Photronics
PLAB
$1.79B
| $463K | ﹤0.01% |
18,685
+3,459
| +23% | +$83.7K |
|
1183
Duolingo
DUOL
$5.7B
| $460K | ﹤0.01% |
1,632
-4,078
| -71% | -$836K |
|
|
BRSL
1184
Brightstar Lottery PLC
BRSL
$1.91B
| $458K | ﹤0.01% |
21,499
+6,944
| +48% | +$149K |
|
1185
Omega Healthcare
OHI
$15.4B
| $457K | ﹤0.01% |
11,240
-413
| -4% | -$15.6K |
|
|
ITCI
1186
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $457K | ﹤0.01% |
6,244
-13,721
| -69% | -$1.03M |
|
1187
Evertec
EVTC
$1.83B
| $456K | ﹤0.01% |
13,444
+3,399
| +34% | +$113K |
|
|
WAY
1188
Waystar Holding Corp
WAY
$4.32B
| $455K | ﹤0.01% |
+16,312
| New | +$402K |
|
1189
Golub Capital BDC
GBDC
$3.33B
| $454K | ﹤0.01% |
30,038
+3,828
| +15% | +$57.8K |
|
|
AGNT
1190
AGNT Inc
AGNT
$664M
| $453K | ﹤0.01% |
32,174
+6,822
| +27% | +$87.9K |
|
|
NARI
1191
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $453K | ﹤0.01% |
10,987
+2,787
| +34% | +$134K |
|
1192
Vontier
VNT
$4.33B
| $452K | ﹤0.01% |
13,400
+6,118
| +84% | +$217K |
|
1193
Keros Therapeutics
KROS
$199M
| $452K | ﹤0.01% |
7,785
+2,118
| +37% | +$105K |
|
1194
Hercules Capital
HTGC
$2.94B
| $452K | ﹤0.01% |
22,996
-775
| -3% | -$15.3K |
|
|
FL
1195
DELISTED
Foot Locker
FL
| $449K | ﹤0.01% |
17,383
+4,736
| +37% | +$131K |
|
1196
Kinsale Capital Group
KNSL
$7.95B
| $449K | ﹤0.01% |
964
-79
| -8% | -$34.9K |
|
1197
Freshworks
FRSH
$2.84B
| $449K | ﹤0.01% |
39,075
+17,361
| +80% | +$208K |
|
1198
Enova International
ENVA
$5.91B
| $447K | ﹤0.01% |
5,336
+996
| +23% | +$77.2K |
|
1199
Aramark
ARMK
$15B
| $445K | ﹤0.01% |
11,484
-919
| -7% | -$32.4K |
|
|
EVRI
1200
DELISTED
Everi Holdings
EVRI
| $444K | ﹤0.01% |
33,827
+22,924
| +210% | +$270K |
|
Similar funds
ProShare Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, ProShare Advisors held 2,151 positions worth $40.8B, up 9.2% from $37.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
ProShare Advisors's Q3 2024 filing shows 303 new, 1,108 increased, 653 reduced and 86 closed positions. Its largest new stake was NexPoint Residential Trust: 319,514 shares worth $14.1M. The largest sale was Qualcomm, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Consumer Staples and Industrials.
- ProShare Advisors's largest Q3 2024 buy was NexPoint Residential Trust: 319,514 shares worth $14.1M.
- ProShare Advisors added most to West Pharmaceutical in Q3 2024, an estimated $197M increase.
- ProShare Advisors's biggest Q3 2024 reduction was Qualcomm, cutting an estimated $230M.
- ProShare Advisors fully exited Atrion Corp in Q3 2024, selling an estimated $8.02M.
- ProShare Advisors's ten largest holdings make up 25% of its $40.8B portfolio in Q3 2024.
- ProShare Advisors opened 303 new positions and closed 86 in Q3 2024.
- ProShare Advisors's portfolio value rose 9.2% quarter-over-quarter to $40.8B.
Based on ProShare Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.